The Regional Portfolio Strategy Headis responsible for defining the long-term strategic direction of the portfolio for assigned therapeutic categories. The role focuses on strategic foresight, opportunity identification, portfolio prioritization, and value creation, ensuring clarity on where to play and how to win. The role provides structured inputs to governance forums and ensures alignment of portfolio strategy across regional and country stakeholders.

ACCOUNTABILITIES

Strategic Foresight & Landscape Assessment - Analyze long-term therapeutic, regulatory, and competitive trends to inform portfolio direction.
Portfolio Prioritization & Road Mapping - Define therapeutic priorities, strategic adjacencies, and 3-10 year portfolio roadmaps.
Opportunity Identification & Business Scoping - Develop opportunity scopes, early concepts, and value hypotheses for strategic bets.
Strategic Frameworks & Decision Support - Build prioritization models, scoring frameworks, and investment recommendations.
Enterprise Alignment & Communication - Drive alignment of portfolio strategy across PPSD, regional HQ, and country teams.

DELIVERABLES

Therapeutic Category Strategy & 3-10 Year Roadmap
Portfolio Prioritization & Scoring Frameworks
Regional Trend Analysis & Scoping including market forecast
Bi-annual regional portfolio strategy review (Brand Summit)
Business cases and assessment for partnerships and opportunistic finds

TARGETS

Portfolio ROI (3-5 year horizon)
Percentage of revenue from strategic therapeutic areas
Pipeline value (risk-adjusted net present value NPV)
Market share growth in priority segments
Time to strategic decision (from new signal to prioritization, review of opportunistic finds)

SKILL SET

Market access strategy, Strategic business development, Market forecast and analytics, Financial modelling, Health economics, Competitive intelligence, Stakeholder management.

REGIONAL PORTFOLIO STRATEGY HEAD - PHARMACEUTICAL BACKGROUND REQUIRED